04:35 PM EDT, 06/26/2024 (MT Newswires) -- Jeffrey V. Poulton, Executive Vice President, Chief Financial Officer, on June 24, 2024, sold 1,605 shares in Alnylam Pharmaceuticals ( ALNY ) for $370,747. Following the Form 4 filing with the SEC, Poulton has control over a total of 28,949 shares of the company, with 28,892 shares held directly and 57 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000067/xslF345X03/edgardoc.xml

Price: 244.43, Change: -0.74, Percent Change: -0.30